Gensight Biologics S.a annual net profit margin
2020
2021
2022
2023
2024
2025
Gensight Biologics S.a Net Profit Margin Growth & History (SIGHT)
Gensight Biologics S.a's net profit margin was −1,203,600.00% for fiscal 2025.
View full Gensight Biologics S.a company overviewGensight Biologics S.a annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −1,203,600.00% | −1202666.60 pp |
| 2024 | 2024-12-31 | −933.40% | +1136.06 pp |
| 2023 | 2023-12-31 | −2,069.46% | −999.55 pp |
| 2022 | 2022-12-31 | −1,069.91% | −527.51 pp |
| 2021 | 2021-12-31 | −542.40% | +231.72 pp |
| 2020 | 2020-12-31 | −774.12% | — |
Gensight Biologics S.a net profit margin trends
Over the last five fiscal years, Gensight Biologics S.a's net profit margin decreased from −774.12% to −1,203,600.00%, a change of −1202825.88 percentage points.
About the metric
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
Calculation and source
How net profit margin is calculated
TickerStat calculates net profit margin as reported net income divided by reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Gensight Biologics S.a source filings ↗Community posts
GenSight advances LUMEVOQ manufacturing transfer to Catalent
GenSight ($SIGHT) said an engineering batch of GS010/LUMEVOQ at Catalent was produced as planned, with viral genome concentration meeting target specifications. Preparations have begun for a GMP-standard batch to supply special-access progr ...